|
|
Perrigo
|
|
Perrigo Agrees To Settle Hatch-Waxman Litigation Related To Minoxidil Foam - RTT News RTT News--(RTTNews) - -Perrigo- Co. (PRGO: News ) Thursday said that it agreed to settle its Hatch-Waxman litigation relating to Minoxidil foam brought by Stiefel ... - Date : Thu, 10 Feb 2011 13:44:56 GMT+00:00 |
Perrigo to settle patent litigation relating to Minoxidil foam - News-Medical.net News-Medical.net---Perrigo- Company (Nasdaq: PRGO; TASE) today announced that it has agreed to settle its Hatch-Waxman litigation relating to Minoxidil foam brought by Stiefel ... - Date : Fri, 11 Feb 2011 08:58:56 GMT+00:00 |
Perrigo 2Q Profit Rises 48% On Stronger Sales, Margins >PRGO - Wall Street Journal Wall Street Journal---Perrigo- Co.'s (PRGO) fiscal second-quarter earnings rose 48% as the store-brand pharmaceutical and nutritional-products maker reported stronger sales and ... - Date : Tue, 01 Feb 2011 13:46:12 GMT+00:00 |
Perrigo (PRGO) Showing Bullish Technicals But Could Fall Through $71.17 Support - Market Intelligence Center Market Intelligence Center---Perrigo- (NASDAQ:PRGO) closed Wednesday's meandering trading session at $72.00. In the past year, the stock has hit a 52-week low of $45.01 and 52-week high ... - Date : Thu, 10 Feb 2011 13:42:09 GMT+00:00 |
Perrigo Company (PRGO) Executive VP & CFO Judy L Brown sells 21978 Shares - GuruFocus.com GuruFocus.com--Executive VP & CFO of -Perrigo- Company (PRGO) Judy L Brown sells 21978 shares of PRGO on 02/07/2011 at an average price of $71.38 a share. ... - Date : Wed, 09 Feb 2011 19:34:58 GMT+00:00 |
Perrigo (PRGO) Trading Near $70.82 Support Level - Market Intelligence Center Market Intelligence Center---Perrigo- (NASDAQ:PRGO) closed Friday's quiet trading session at $71.67. In the past year, the stock has hit a 52-week low of $44.70 and 52-week high of ... - Date : Mon, 07 Feb 2011 13:47:41 GMT+00:00 |
Perrigo fiscal 2Q profit jumps 48 percent - Bloomberg Bloomberg--(AP) � -Perrigo- Co., which makes store-brand over-the-counter drugs and infant formulas, said Tuesday its fiscal second-quarter earnings jumped 48 percent, ... - Date : Tue, 01 Feb 2011 19:32:48 GMT+00:00 |
Clearing commuter lots, intersections next priority for Glen Ellyn - TribLocal TribLocal--Interim Public Works Director Jeff -Perrigo- said Friday that all village streets should be passable and open to at least two directional lanes. ... - Date : Fri, 04 Feb 2011 17:27:20 GMT+00:00 |
Cramer's Mad Money - Perrigo Is Drinking Johnson & Johnson's Milkshake (2/1/11) - Seeking Alpha Seeking Alpha--Cramer told viewers last week to keep an eye on -Perrigo- (PRGO), the "king of knock-off over the counter drugs" and the main beneficiary of Johnson ... - Date : Wed, 02 Feb 2011 11:21:48 GMT+00:00 |
Goldman Sachs (GS) Analysts Raise Price Target on Perrigo (PRGO) Shares to $56.00 - American Banking News American Banking News--Equities research analysts at Goldman Sachs (NYSE: GS) boosted their price target on shares of -Perrigo- (NASDAQ: PRGO) to $56.00 in a research note to ... - Date : Thu, 03 Feb 2011 17:14:26 GMT+00:00 |
: Executive Officers | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Name | Position | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Joseph C. Papa | Chairman, President and Chief Executive Officer | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judy L. Brown | Executive Vice President and Chief Financial Officer | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thomas M. Farrington | Senior Vice President and Chief Information Officer | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
John T. Hendrickson | Executive Vice President, Global Operations and Supply Chain | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Todd W. Kingma | Executive Vice President, General Counsel and Secretary | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sharon Kochan | Executive Vice President, U.S. Generics | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refael Lebel | Executive Vice President and President, Perrigo Israel | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Jeffrey R. Needham | Executive Vice President & General Manager Consumer Healthcare Business | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Jatin Shah, Ph.D. | Senior Vice President and Chief Scientific Officer | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Michael R. Stewart | Senior Vice President, Global Human Resources | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
James C. Tomshack | Senior Vice President, Consumer Healthcare Sales | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Louis W. Yu, Ph.D. | Senior Vice President, Global Quality and Compliance |
: Current Employees | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Country | Total Number of Employees | Number of Employees Covered by Collective Bargaining Agreements | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4,200 | 250 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Israel | 1,650 | 450 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mexico | 800 | 400 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
U.K. | 500 | - | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rest of the world | 100 | 85 |
Teva Pharmaceutical Industries * BAZAN - Oil Refineries * Bezeq - The Israel Telecommunication Corp * Cellcom * Delek Group * Israel Discount Bank * Discount Investment Corporation * Elbit Systems * Harel Group * Israel Chemicals * Israel Corporation * Delek Drilling LP * Bank Leumi * MA Industries * Avner Oil Exploration LP * Bank Mizrahi-Tfahot * NICE Systems * Ormat Industries * Partner Communications Company * Paz Oil Company * Perrigo Company * Bank Hapoalim * Strauss Group * Osem * Gazit-Globe * |